GenMark Dx's mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies.
For investor information, please contact IR@genmarkdx.com.
May 5, 2015
GenMark Diagnostics Reports Q1 Financial Results
Jun 10, 2015 at 3:20 PM CT
William Blair 35th Annual Growth Stock Conference